EcoDrugPlus

Coagulation Factor Vii-Like

Ensembl ID : ENSPFOG00000023877
Gene Symbol: LOC103130091
3 Cross references
78 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSPFOG00000024702
Gene Symbol: LOC103130090
3 Cross references
238 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSPFOG00000023666
Gene Symbol: LOC103130089
3 Cross references
233 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSPFOG00000015438
Gene Symbol: LOC103143314
2 Cross references
204 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSPFOG00000023111
Gene Symbol: CCDC6
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSPFOG00000001866
Gene Symbol: LOC103131704
2 Cross references
194 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSPFOG00000023556
Gene Symbol: LOC103129780
2 Cross references
280 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPFOG00000003496
Gene Symbol: CSF1R
4 Cross references
62 Possible Orthologues:

Complement C5

Ensembl ID : ENSPFOG00000008758
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1-Like

Ensembl ID : ENSPFOG00000013545
Gene Symbol: LOC103151070
2 Cross references
207 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSPFOG00000008228
Gene Symbol: CCND1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSPFOG00000008012
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).